The efficacy and safety of immune checkpoint inhibitor plus chemotherapy in patients with advanced non-small-cell lung cancer: a meta-analysis
Li-Fang Meng, Jianfeng Huang, Peng‐Hui Luo, Shang‐Xiao Huang, Han‐Lei Wang
Topics & Concepts
MedicineAtezolizumabNivolumabInternal medicinePembrolizumabIpilimumabHazard ratioLung cancerOncologyAdverse effectChemotherapyOdds ratioCancerGastroenterologyImmunotherapyConfidence intervalCancer Immunotherapy and BiomarkersLung Cancer Diagnosis and TreatmentLung Cancer Research Studies